An ADHD medication dose increase is typically considered when your current dose isn’t reducing symptoms enough to improve how you actually function in daily life, or when a dose that previously worked well starts losing its effect. The process follows a “start low, go slow” approach, with most guidelines recommending a 4- to 6-week titration period to find the right balance between symptom relief and side effects.
Signs Your Current Dose Isn’t Enough
The clearest signal that a dose increase may be warranted isn’t just that you still have ADHD symptoms. It’s that those symptoms are still getting in the way of your life. A dose that takes the edge off inattention but doesn’t actually help you complete tasks at work, follow conversations, or manage daily responsibilities may not be doing enough. The clinical standard for “inadequate response” is a dose that fails to produce meaningful functional improvement, not just a partial reduction in symptoms on paper.
Some patterns worth tracking:
- Consistent difficulty with focus, organization, or impulse control despite taking your medication as prescribed for several weeks
- Symptom coverage gaps during the day where the medication seems to wear off hours before your day ends
- Initial improvement that has plateaued at a level that still leaves you struggling in key areas of your life
Your prescriber may use a structured rating scale to get an objective picture. The Adult ADHD Self-Report Scale (ASRS) and the Conners’ Adult ADHD Rating Scales (CAARS) are commonly used both at diagnosis and during treatment to track whether symptoms are actually shifting with each dose change. Functional impairment scales, like the Weiss Functional Impairment Rating Scale, can capture whether improvements in attention are translating into real-world gains at work, in relationships, and in self-care. These tools help separate “I had a bad week” from a genuine pattern of insufficient medication response.
How Stimulant Doses Are Typically Increased
For stimulant medications, the standard approach across major clinical guidelines is to start at a low dose and increase gradually, usually on a weekly basis, until you hit one of three endpoints: your symptoms improve meaningfully, side effects become limiting, or you reach the maximum recommended dose.
British guidelines recommend titrating over 4 to 6 weeks, with a maximum of 100 mg per day for adults on methylphenidate-based medications. Swedish guidelines suggest weekly increases to find the best balance between benefit and side effects, with a ceiling of 80 mg per day. In practice, the FDA-approved maximums for the most commonly prescribed stimulants are 60 mg per day for immediate-release methylphenidate, 40 mg per day for mixed amphetamine salts, and 70 mg per day for lisdexamfetamine.
These ceilings matter because they set a boundary on how far titration can go. If you’re approaching the maximum dose without adequate symptom control, that’s typically a conversation about switching medications rather than continuing to push the dose higher.
Non-Stimulant Medications Follow a Slower Timeline
If you’re on atomoxetine, the timeline for dose increases is longer and more structured. The standard protocol starts at 40 mg per day for at least 3 days before increasing to a target dose of 80 mg per day. If that target dose isn’t producing a good enough response after an additional 2 to 4 weeks, the dose can be pushed to a maximum of 100 mg per day.
Some prescribers use an even more gradual approach, starting at 25 mg per day for a week, stepping up to 40 mg for another week, and then moving to 80 mg. This slower ramp-up can reduce side effects like nausea and dizziness that sometimes lead people to abandon the medication before it’s had a fair chance. Importantly, atomoxetine’s full effect can take weeks to emerge. Pooled data from clinical trials show that symptom improvement continues to build over months of treatment, so patience with this class of medication is more critical than with stimulants, which tend to show effects within hours.
When a Previously Effective Dose Stops Working
Tolerance to stimulant medication is real, though estimates of how common it is vary widely. One study found that about 25% of patients developed tolerance within days to weeks. Another long-term study put the figure at just 2.7% over 10 years. A third found that a significant portion of nearly 10,000 adults lost some medication benefit over just 26 weeks. The honest answer is that researchers don’t have a precise number, but the phenomenon is well recognized.
There’s a biological mechanism behind it. Brain imaging research on adults taking methylphenidate for 12 months showed a 24% increase in the density of dopamine transporters, the proteins that clear dopamine from the spaces between brain cells. More transporters means the brain is working harder to counteract the medication’s effect. Interestingly, in that particular study, clinical symptom ratings stayed stable throughout the year despite the biological change, but the researchers noted that this adaptation could eventually reduce the drug’s effectiveness.
If you’ve been on a stable dose for months or years and notice a gradual return of symptoms, that’s worth bringing to your prescriber. The solution might be a modest dose increase, a switch to a different formulation, or adding a non-medication strategy to pick up the slack.
Hormonal Fluctuations Can Mimic the Need for a Dose Change
For women, hormonal shifts can make ADHD medication seem less effective at certain times, even when the dose itself is fine. Estrogen appears to enhance the way stimulants work on dopamine systems, so medication may feel stronger during high-estrogen phases of the menstrual cycle and weaker during the premenstrual week when estrogen drops. In a small case study, increasing the stimulant dose during the premenstrual week led all nine participants to report improved mood, energy, and ADHD symptom control.
Menopause presents a longer-term version of this pattern. As estrogen levels decline permanently, stimulant effectiveness may drop as well. Some clinicians address this with dosage adjustments, changes in medication timing, or by coordinating with hormone therapy. If your medication feels inconsistent on a monthly cycle, tracking your symptoms alongside your cycle for two to three months can give your prescriber the data they need to adjust your regimen thoughtfully rather than just bumping the dose up across the board.
Genetic Differences in How You Process Medication
Your body’s ability to break down certain ADHD medications is partly determined by genetics, specifically variations in a liver enzyme called CYP2D6. People who metabolize drugs through this pathway unusually slowly (called poor metabolizers) can end up with higher drug levels than expected at a standard dose, meaning they may not need increases as quickly and may be more sensitive to side effects. The FDA recommends limiting dose increases for these individuals.
On the other end, people who metabolize drugs unusually fast may not get adequate benefit from standard doses because the medication clears their system too quickly. Clinical data shows these faster metabolizers tend to show less symptom improvement in the first few weeks of treatment, though outcomes often even out by week four. This is most relevant for atomoxetine, which is heavily processed by CYP2D6. Stimulants are metabolized through different pathways, so this genetic factor plays a smaller role with medications like methylphenidate or amphetamine.
What the Process Looks Like in Practice
A dose increase typically isn’t something you decide on your own. The process usually involves a check-in with your prescriber where you discuss how well the current dose is covering your symptoms throughout the day, what side effects you’re experiencing, and whether your functioning has improved in the areas that matter most to you. Many clinicians will ask you to fill out a brief rating scale or bring notes on how your week has gone.
If an increase is warranted, the change is usually small, one step up in the available dosing options, and you’ll likely be asked to report back in one to two weeks. The goal is to find the lowest dose that produces meaningful improvement without intolerable side effects. This sweet spot, sometimes called the therapeutic window, is different for everyone. Some adults do well on relatively low doses. Others need doses near the maximum to get adequate coverage.
Side effects that commonly intensify with dose increases include appetite suppression, difficulty sleeping, elevated heart rate, and feeling jittery or “wired.” A good dose increase improves your focus and functioning without making you feel like a different person. If a higher dose controls your symptoms but leaves you unable to eat, sleep, or relax, that’s usually a sign you’ve overshot the window, and your prescriber will likely step back down to the previous dose.